Pacira Pharmaceuticals, Inc.【PCRX】 売上原価の推移
機能の使い方
|
（単位：千ドル）
|
売上原価
|
前年比（％）
|
|
4Q25
|
40,299
|
+1.0%
|
|
3Q25
|
34,278
|
-11.8%
|
|
2Q25
|
40,866
|
-7.7%
|
|
1Q25
|
34,306
|
-27.6%
|
|
4Q24
|
39,886
|
-16.4%
|
|
3Q24
|
38,864
|
-2.2%
|
|
2Q24
|
44,262
|
-8.2%
|
|
1Q24
|
47,416
|
-3.3%
|
|
4Q23
|
47,692
|
-23.0%
|
|
3Q23
|
39,750
|
-21.6%
|
|
2Q23
|
48,207
|
-4.8%
|
|
1Q23
|
49,020
|
+35.9%
|
|
4Q22
|
61,916
|
+58.7%
|
|
3Q22
|
50,678
|
+46.3%
|
|
2Q22
|
50,627
|
+43.6%
|
|
1Q22
|
36,074
|
+15.1%
|
|
4Q21
|
39,007
|
+10.5%
|
|
3Q21
|
34,651
|
+15.5%
|
|
2Q21
|
35,248
|
+58.0%
|
|
1Q21
|
31,349
|
+5.4%
|
|
4Q20
|
35,298
|
+10.6%
|
|
3Q20
|
29,993
|
+34.5%
|
|
2Q20
|
22,305
|
-11.5%
|
|
1Q20
|
29,732
|
+8.9%
|
|
4Q19
|
31,904
|
+33.0%
|
|
3Q19
|
22,304
|
+17.0%
|
|
2Q19
|
25,201
|
+20.5%
|
|
1Q19
|
27,303
|
+19.3%
|
|
4Q18
|
23,979
|
+12.6%
|
|
3Q18
|
19,065
|
+4.6%
|
|
2Q18
|
20,916
|
-12.2%
|
|
1Q18
|
22,885
|
-6.9%
|
|
4Q17
|
21,295
|
-9.8%
|
|
3Q17
|
18,228
|
-57.8%
|
|
2Q17
|
23,811
|
+3.3%
|
|
1Q17
|
24,581
|
+21.2%
|
|
4Q16
|
23,621
|
+21.6%
|
|
3Q16
|
43,152
|
+171.4%
|
|
2Q16
|
23,053
|
+21.8%
|
|
1Q16
|
20,278
|
+15.3%
|
|
4Q15
|
19,427
|
+2.4%
|
|
3Q15
|
15,901
|
-22.0%
|
|
2Q15
|
18,929
|
-5.1%
|
|
1Q15
|
17,580
|
-3.0%
|
|
4Q14
|
18,968
|
+3.2%
|
|
3Q14
|
20,391
|
+37.9%
|
|
2Q14
|
19,954
|
+95.4%
|
|
1Q14
|
18,127
|
+59.1%
|
|
4Q13
|
18,376
|
+90.0%
|
|
3Q13
|
14,791
|
+59.3%
|
|
2Q13
|
10,214
|
+52.8%
|
|
1Q13
|
11,391
|
+75.4%
|
|
4Q12
|
9,672
|
+46.5%
|
|
3Q12
|
9,287
|
+176.6%
|
|
2Q12
|
6,685
|
+114.6%
|
|
1Q12
|
6,495
|
-
|
|
4Q11
|
6,601
|
-
|
|
3Q11
|
3,357
|
-
|
|
2Q11
|
3,115
|
-
|